RALGAPA2 and cancer: However, low expression of RalGAPα2 leads to an increase in tumor cell proliferation, invasion, and migration in cancer cell lines or mouse models of hepatocellular carcinoma31, colitis-associated cancer32, oral squamous cell carcinoma33, prostate cancer34, and bladder cancer35.